Imaging study of urologic cancer with radiogenomics
Part of Cancer, Kidney & urinary, Women’s health & pregnancy clinical trials.
This study looks at how scans (CT or MRI) can help doctors understand the environment around urologic tumors. It may lead to better ways to predict treatment response and outcomes.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are being treated for a urologic cancer (such as kidney, bladder, or prostate cancer) at Wuhan Union Hospital between August 2024 and August 2027.
- You are 18 years old or older.
- You had a CT scan or MRI scan before starting your cancer treatment.
- A tissue biopsy confirmed your urologic cancer diagnosis.
- Your medical images are clear and your health records are complete.
- You do not have another type of cancer besides the urologic cancer.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies a new way to use medical scans to better find lymph nodes and nearby urologic organs before surgery. It may help surgeons plan operations for cancers or other conditions in the urologic area.
This study uses a special MRI scanner in the operating room to help guide lymph node removal during surgery for urologic cancers like bladder, prostate, testicular, kidney, urethral, or penile cancer. It aims to see if this real-time imaging can make the surgery more precise.
This study looks at how CT scans of lung cancer can be linked to the tumor's biology and genetics. It aims to understand lung cancer better by combining imaging with lab results.
This trial collects and analyzes imaging, lab tests, and tissue samples from people with bladder, kidney, or prostate cancer. The goal is to see how combining these different types of information can improve diagnosis and treatment decisions.
This study looks at how liver cancer appears on CT or MRI scans and how it connects with the tumor's biology. It aims to find better ways to understand and treat liver cancer by linking imaging features with the tumor environment.
This study uses artificial intelligence and CT scan analysis to predict how well lung cancer patients will respond to immunotherapy. It may help doctors choose the best treatment for you.
Hear when a new Urologic Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.